(THRO) iShares U.S. Thematic - Ratings and Ratios

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: (N/A)

THRO: Equity, Securities, Stocks, Investment, Portfolio

The iShares U.S. Thematic Rotation Active ETF (NYSE ARCA:THRO) is an actively managed exchange-traded fund that focuses on investing in U.S. equity securities with high growth potential. Under normal market conditions, the fund allocates at least 80% of its net assets to U.S. equities that BlackRock Fund Advisors (BFA) believes possess above-average earnings growth prospects.

The funds investment universe includes a range of equity securities such as common stocks, preferred stocks, convertible securities, warrants, and depositary receipts tied to the value of common stock. As a non-diversified fund, THRO may concentrate its investments in a smaller number of securities, potentially increasing its exposure to individual stock risks.

Analyzing the funds recent performance and technical indicators, we observe that the last price is $32.46, with a 20-day simple moving average (SMA) of $31.37 and a 50-day SMA of $31.68, indicating a recent uptrend. The 200-day SMA stands at $32.70, suggesting that the fund is slightly below its long-term average. The average true range (ATR) is 0.84, equivalent to 2.60% of the last price, indicating moderate volatility.

Considering the funds assets under management (AUM) of $561.63 million, we can infer that THRO has a reasonable size, allowing for decent liquidity. Given the current technical and fundamental data, a forecast for THRO could be that it continues to trend upwards, potentially reaching the upper end of its 52-week range, around $35.41, if the growth prospects of its underlying securities materialize. However, a decline below the 52-week low of $28.66 could occur if the market sentiment shifts negatively. A more likely scenario, based on the current SMA indicators and moderate volatility, is that THRO will continue to consolidate around its current price, potentially oscillating between $31 and $34 in the short term.

Additional Sources for THRO ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

THRO ETF Overview

Market Cap in USD 4,568m
Category Large Blend
IPO / Inception 2021-12-14

THRO ETF Ratings

Growth Rating 48.2
Fundamental -
Dividend Rating 33.5
Rel. Strength -0.95
Analysts -
Fair Price Momentum 31.77 USD
Fair Price DCF -

THRO Dividends

Dividend Yield 12m 0.67%
Yield on Cost 5y 0.92%
Annual Growth 5y 9.92%
Payout Consistency 92.9%
Payout Ratio %

THRO Growth Ratios

Growth Correlation 3m 77.8%
Growth Correlation 12m 44.2%
Growth Correlation 5y 86.3%
CAGR 5y 10.24%
CAGR/Max DD 5y 0.39
Sharpe Ratio 12m 1.44
Alpha -1.41
Beta 1.049
Volatility 12.93%
Current Volume 774.9k
Average Volume 20d 1161.8k
What is the price of THRO shares?
As of June 15, 2025, the stock is trading at USD 34.20 with a total of 774,919 shares traded.
Over the past week, the price has changed by -1.33%, over one month by +0.94%, over three months by +10.06% and over the past year by +10.40%.
Is iShares U.S. Thematic a good stock to buy?
Partly, yes. Based on ValueRay´s Analyses, iShares U.S. Thematic (NYSE ARCA:THRO) is currently (June 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 48.17 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of THRO is around 31.77 USD . This means that THRO is currently overvalued and has a potential downside of -7.11%.
Is THRO a buy, sell or hold?
iShares U.S. Thematic has no consensus analysts rating.
What are the forecasts for THRO share price target?
According to our own proprietary Forecast Model, THRO iShares U.S. Thematic will be worth about 36.4 in June 2026. The stock is currently trading at 34.20. This means that the stock has a potential upside of +6.55%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 36.4 6.5%